CORRECTING and REPLACING Cybin Announces Up to USD$35 Million At-The-Market Equity Program Life Science Investing
Cybin Inc. Reports First Quarter Financial Results and Recent Business Highlights Life Science Investing
AMGEN DATA AT WCLC 2022 HIGHLIGHTS POTENTIAL TO DELIVER TRANSFORMATIVE MEDICINES FOR HISTORICALLY DIFFICULT-TO-TREAT LUNG CANCERS Market News
The Gummy Project Secures Additional Repeat Order from Existing Customer Flair Airlines Life Science Investing
